Two experts in medical oncology explore the latest developments in metastatic colorectal cancer in this episode of the EMJ podcast. Elena Élez, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology, Barcelona, Spain; and Michel Ducreux, Gustave Roussy, Villejuif, France, and Paris-Saclay University, France, discuss current treatment guidelines for patients with mCRC BRAF V600E mutation.

This podcast has been funded by Pierre Fabre; the position and discussions might not represent the position of Pierre Fabre.